Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on Nektar Therapeutics and Santarus

Continue Reading

U.S. Housing Market Recovery Continues as Prices in November Post Largest Gains in 6 1/2 Years

Five Star Equities Provides Stock Research on KB Home and Lennar

Continue Reading

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on Orexigen Therapeutics and Pluristem Therapeutics

Continue Reading

Homebuilder-s Continue Rally as Home Prices Surge 7.4% November

Five Star Equities Provides Stock Research on PulteGroup and Toll Brothers

Continue Reading

Demand for Natural Gas Vehicles Growing Worldwide — 1 Million New NGV Trucks and Buses to be Sold by 2019

Five Star Equities Provides Stock Research on Westport Innovations and Fuel Systems Solutions

Continue Reading

Natural Gas Vehicle Market to Be Driven by Rapidly Growing Trucks and Buses Market

Five Star Equities Provides Stock Research on Clean Energy Fuels and Quantum Fuel Systems

Continue Reading

Biotech Industry Expected to Experience More M&A Activity in 2013

Five Star Equities Provides Stock Research on Amicus Therapeutics and Zalicus

Continue Reading

Major Revenue Losses From Patent Expirations Forces Big Pharma Companies to Look to the Biotech Industry for Replacements

Five Star Equities Provides Stock Research on Arena Pharmaceuticals and VIVUS

Continue Reading

Record Levels of Available Cash and Moderate R&D Development Will See Big Pharma M&A Activity Increase in 2013

Five Star Equities Provides Stock Research on ACADIA Pharmaceuticals and Halozyme Therapeutics

Continue Reading

Mergers and Acquisitions Within the Biotech Industry Expected to Rise in 2013

Five Star Equities Provides Stock Research on Keryx Biopharmaceuticals and Novavax

Continue Reading